← Back to Search

ACT Intervention for Dementia

N/A
Waitlist Available
Led By Pamela Durepos, PhD
Research Sponsored by University of New Brunswick
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion up to 1 year
Awards & highlights

Study Summary

This trial will explore whether a new counseling program can improve mental health for people who care for loved ones with dementia, in Canada. 80 people will be recruited and randomly assigned to either the counseling program or to usual care services, and mixed methods will be used to evaluate the potential impact of the counseling program.

Eligible Conditions
  • Dementia
  • Counseling
  • Psychotherapy
  • Caregiver Burden
  • Mental Health
  • Acceptance and Commitment Therapy
  • Digital Health
  • Technology

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Baseline Caregiver Burden up to 36 weeks as assessed by the Zarit Burden Index
Change in Baseline Caregiver Participation in Meaningful and Fulfilling Activities up to 36 weeks as assessed by the Engagement in Meaningful Activities Scale
Change in Baseline Depression, Anxiety and Stress up to 36 weeks as assessed by the Depression, Anxiety and Stress Scale
+1 more
Secondary outcome measures
Acceptability of ACT Intervention Technology Used for Remote Delivery up to 36 weeks as assessed by the System Usability Scale
Feasibility and Acceptability of Implementing the ACT Intervention as planned through study completion up to 1 year as assessed by recruitment, retention and attrition rates, and participant demographics
Satisfaction with ACT Intervention Delivery, Content and Processes up to 36 weeks as assessed by the Client Satisfaction Questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: ACT InterventionExperimental Treatment1 Intervention
Participants will attend 6-8 individual psychotherapy sessions via telephone, text or videoconference. Sessions will last approximately 1 hour and occur every 3-4 weeks. Participants will be enrolled in the Intervention Group for 18-36 weeks. All sessions will be audio recorded. Participants will also be able to attend all available usual care services such as: support groups, First Link, education classes at the Alzheimer Society. Any services utilized will be documented by Alzheimer Society staff.
Group II: Usual CareActive Control1 Intervention
Participants will be enrolled as an Alzheimer Society client. Participants will receive 1 First Link 'check-in' telephone call from a staff member at the time of enrolment. Participants will receive a 2nd 'check-in' First Link telephone call from a staff member 3-4 months following enrolment. Participants will be enrolled in the Usual Care Group 12-16 weeks. Participants will also be able to attend all available usual care services such as: support groups, etc. Any services utilized will be documented by Alzheimer Society staff.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ACT Intervention
2022
N/A
~30

Find a Location

Who is running the clinical trial?

University of New BrunswickLead Sponsor
22 Previous Clinical Trials
2,528 Total Patients Enrolled
1 Trials studying Dementia
41 Patients Enrolled for Dementia
Mount Allison UniversityUNKNOWN
McMaster UniversityOTHER
880 Previous Clinical Trials
2,597,798 Total Patients Enrolled
7 Trials studying Dementia
900,873 Patients Enrolled for Dementia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many different individuals are being monitored in this research project?

"That is accurate. The listing on clinicaltrials.gov verifies that this trial is open and looking for patients. It was originally posted on May 30th, 2022 and most recently updated on October 31st, 2022. They are trying to enroll 80 people at a single location."

Answered by AI

Who else is applying?

What state do they live in?
New Brunswick
How old are they?
18 - 65
What site did they apply to?
Alzheimer Society of New Brunswick
What portion of applicants met pre-screening criteria?
Met criteria
~11 spots leftby Apr 2025